|
NDE1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.09401376846563E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.43400912944981E-12 |
| Normal-vs-Stage2 |
2.588500E-04 |
| Normal-vs-Stage3 |
1.84728999998995E-05 |
| Normal-vs-Stage4 |
4.14709999996266E-06 |
| Stage1-vs-Stage2 |
5.415000E-01 |
| Stage1-vs-Stage3 |
4.969400E-01 |
| Stage1-vs-Stage4 |
4.899000E-01 |
| Stage2-vs-Stage3 |
9.887000E-01 |
| Stage2-vs-Stage4 |
3.206600E-01 |
| Stage3-vs-Stage4 |
2.793400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.83317813654094E-12 |
| Normal-vs-AfricanAmerican |
5.400100E-03 |
| Normal-vs-Asian |
2.051600E-02 |
| Caucasian-vs-AfricanAmerican |
1.846550E-01 |
| Caucasian-vs-Asian |
7.291800E-02 |
| AfricanAmerican-vs-Asian |
2.954400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.5839995981537E-11 |
| Normal-vs-Female |
6.49019948895102E-10 |
| Male-vs-Female |
6.632000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.035880E-02 |
| Normal-vs-Age(41-60Yrs) |
6.73416877816635E-12 |
| Normal-vs-Age(61-80Yrs) |
1.79509995756888E-09 |
| Normal-vs-Age(81-100Yrs) |
6.725700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.765000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.669800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.109600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.280800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.928250E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.915200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.79549999979045E-07 |
| Normal-vs-Grade 2 |
1.30329969039167E-10 |
| Normal-vs-Grade 3 |
9.15829967418347E-10 |
| Normal-vs-Grade 4 |
1.789770E-04 |
| Grade 1-vs-Grade 2 |
1.813610E-01 |
| Grade 1-vs-Grade 3 |
2.369000E-01 |
| Grade 1-vs-Grade 4 |
3.170200E-01 |
| Grade 2-vs-Grade 3 |
9.288600E-01 |
| Grade 2-vs-Grade 4 |
6.152400E-01 |
| Grade 3-vs-Grade 4 |
6.556800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.68554059598591E-12 |
| Normal-vs-ccB subtype |
9.55670000024611E-07 |
| ccA subtype-vs-ccB subtype |
1.856770E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.98210053609694E-10 |
| Normal-vs-N1 |
1.154420E-02 |
| N0-vs-N1 |
2.330800E-01 |
|
|
